Dear CCPBioSim and Bioscience colleagues,

CCPBioSim are very excited to be hosting the online seminar “ExCALIBUR 
Programme: Progress and Upcoming Calls” by Elizabeth Bent from EPSRC and "UK 
Exascale Supercomputer Project: Plans and Opportunities" Mark Parsons from 
EPCC. The seminar will take place on 2 March 2022 at 13:30 British time. The 
details and registration link can be found at 
https://www.ccpbiosim.ac.uk/excalibur2022. The registration deadline is 28 
February 2022.



This seminar is aimed at UK bioscientists who rely on computation for their 
research. The exciting potential of exascale computing for biosciences is that 
it offers us 1000 fold more capability, but there are challenges to be 
overcome, as Mark will explain. Elizabeth will describe the UKRI aspirations 
for exascale, and how they will support us.



We very much hope that you can join us for the talk and for the discussion 
afterwards!

Sarah Harris, Mark Parson, Elizabeth Bent.


This email and any attachments are intended solely for the use of the named 
recipients. If you are not the intended recipient you must not use, disclose, 
copy or distribute this email or any of its attachments and should notify the 
sender immediately and delete this email from your system. UK Research and 
Innovation (UKRI) has taken every reasonable precaution to minimise risk of 
this email or any attachments containing viruses or malware but the recipient 
should carry out its own virus and malware checks before opening the 
attachments. UKRI does not accept any liability for any losses or damages which 
the recipient may sustain due to presence of any viruses.


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to